silibinin

You have access
Hypoxia-inducible Factor-1α Suppression in Ovarian Clear-cell Carcinoma Cells by Silibinin Administration
MARIKO MIYAZAWA, MASANORI YASUDA, MASAKI MIYAZAWA, NAOKI OGANE, TOMOMI KATOH, MITSUTAKE YANO, TAKESHI HIRASAWA, MIKIO MIKAMI and HITOSHI ISHIMOTO

Anticancer Research December 2020, 40 (12) 6791-6798; DOI: https://doi.org/10.21873/anticanres.14702
You have access
Sensitization of rhTRAIL-resistant Triple-negative Breast Carcinoma Through Silibinin Co-Treatment
JASMINE M. MANOUCHEHRI and MICHAEL KALAFATIS

Anticancer Research December 2017, 37 (12) 6593-6599;
You have access
The Effect of Silibinin in Enhancing Toxicity of Temozolomide and Etoposide in p53 and PTEN-mutated Resistant Glioma Cell Lines
RASHID ELHAG, ELIZABETH A. MAZZIO and KARAM F.A. SOLIMAN

Anticancer Research March 2015, 35 (3) 1263-1269;
You have access
Silibinin Administration Improves Hepatic Failure Due to Extensive Liver Infiltration in a Breast Cancer Patient
JOAQUIM BOSCH-BARRERA, BRUNA COROMINAS-FAJA, ELISABET CUYÀS, BEGOÑA MARTIN-CASTILLO, JOAN BRUNET and JAVIER A. MENENDEZ

Anticancer Research August 2014, 34 (8) 4323-4327;
You have access
Silibinin Down-regulates Expression of Secreted Phospholipase A₂ Enzymes in Cancer Cells
ALBERT HAGELGANS, BRIT NACKE, MARIA ZAMARAEVA, GABRIELE SIEGERT and MARIO MENSCHIKOWSKI

Anticancer Research April 2014, 34 (4) 1723-1729;

Main menu